The trademark application UBLYXI was filed by TG Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on July 19, 2020, and it was registered by office on December 21, 2020 without any oppositions.
The application was filed in English (German was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on January 10, 2023.